missed tirzepatide shot Missing a Dose by One Day? Here's What to Know What to do if you

Pregnancy Planning Retatrutide is contraindicated during pregnancy and breastfeeding

These changes explain the range of gastrointestinal symptoms patients experience, from diarrhea to constipation

After reviewing clinical evidence, Wegovy tablets were approved by the MHRA on 11 June 2026

Key Highlights: Lower Limit of Quantification (LLOQ): 1.0 ng/mL

There is no official contraindication listed in the Summary of Product Characteristics (SmPC) for tirzepatide that specifically prohibits its use in people with bipolar disorder

Among these, gastrointestinal disturbances, particularly gas and bloating, are frequently reported by users, reflecting the drugs complex interaction with the digestive system